Kemnay Advisory Services’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Kemnay Advisory Services's XERS Position: Q3 2026 in Review
Kemnay Advisory Services opened a new position in Xeris Biopharma Holdings (XERS) in Q3 2026: 1,662 shares worth $15.9K. The stake represents ﹤0.01% of the portfolio and ranks #620 among its holdings. This is a return to the name: Kemnay Advisory Services previously reported a position in XERS as recently as Q1 2026.
Kemnay Advisory Services first reported a position in XERS in Q4 2025 and has held it in 3 quarters since. The position peaked at $106K in Q1 2026. 248 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Kemnay Advisory Services held 1,662 shares of Xeris Biopharma Holdings worth $15.9K as of Q3 2026.
- Xeris Biopharma Holdings was a new Kemnay Advisory Services position in Q3 2026.
- Xeris Biopharma Holdings made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q3 2026, its #620 holding.
- Kemnay Advisory Services first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 3 quarters since.
- Kemnay Advisory Services's Xeris Biopharma Holdings position peaked at $106K in Q1 2026.
- 248 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.